Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.

about

Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.

Item

http://www.wikidata.org/entity/Q40254788

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Medical Therapies for Strictur ...... ictors of Therapeutic Failure.

@en

type

Item

label

Medical Therapies for Strictur ...... ictors of Therapeutic Failure.

@en

prefLabel

Medical Therapies for Strictur ...... ictors of Therapeutic Failure.

@en

P1476

Medical Therapies for Strictur ...... ictors of Therapeutic Failure.

@en

P2093

Anne Dubois

http://www.w3.org/2001/XMLSchema#string

Anthony Buisson

http://www.w3.org/2001/XMLSchema#string

Antoine Perrey

http://www.w3.org/2001/XMLSchema#string

Bruno Pereira

http://www.w3.org/2001/XMLSchema#string

Constance Hordonneau

http://www.w3.org/2001/XMLSchema#string

Cécile Campos

http://www.w3.org/2001/XMLSchema#string

Céline Lambert

http://www.w3.org/2001/XMLSchema#string

Felix Goutorbe

http://www.w3.org/2001/XMLSchema#string

Gilles Bommelaer

http://www.w3.org/2001/XMLSchema#string

Marion Goutte

http://www.w3.org/2001/XMLSchema#string

P2860

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Infliximab maintenance therapy for fistulizing Crohn's disease

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

Epidemiology and natural history of inflammatory bowel diseases

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.

Incidence and clinical course of Crohn's disease during the first year - results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009.

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

Adalimumab for the treatment of fistulas in patients with Crohn's disease

Effect of infliximab on small bowel stenoses in patients with Crohn's disease

Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.

P2888

s10620-017-4572-4

P304

1628-1636

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-017-4572-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28401425

http://www.w3.org/2001/XMLSchema#string